Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: Multi-parametric assessment and direct evidence

Pain

Volumn 152, Issue 1, 2011, Pages 170-181

  Meyer, Laurence ^a   Patte Mensah, Christine ^a   Taleb, Omar ^a   Mensah Nyagan, Ayikoe Guy ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Allodynia; Analgesia; Cancer and pain; Hyperalgesia; Neuroprotection; Nociception

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; MYELIN PROTEIN; OXALIPLATIN;

ACTION POTENTIAL; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; AXOPLASM FLOW; BEHAVIORAL SCIENCE; BRAIN ELECTROPHYSIOLOGY; COLD ALLODYNIA; CONFOCAL MICROSCOPY; CONTROL GROUP; CONTROLLED STUDY; DRUG MECHANISM; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MALE; MECHANICAL ALLODYNIA; MECHANICAL PAIN THRESHOLD; NERVE CONDUCTION; NERVE FIBER; NEUROFILAMENT; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PAIN THRESHOLD; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL GANGLION; THERMAL PAIN THRESHOLD;

EID: 78650415465     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2010.10.015     Document Type: Article

References (80)

1. S. Agthong, A. Kaewsema, N. Tanomsridejchai, and V. Chentanez Activation of MAPK ERK in peripheral nerve after injury BMC Neurosci 7 2006 45 52
2. Y. Akwa, R.H. Purdy, G.F. Koob, and K.T. Britton The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat Behav Brain Res 106 1999 119 125
3. A.A. Argyriou, P. Polychronopoulos, G. Iconomou, E. Chroni, and H.P. Kalofonos A review on oxaliplatin-induced peripheral nerve damage Cancer Treat Rev 34 2008 368 377
4. N. Authier, D. Balayssac, F. Marchand, B. Ling, A. Zangarelli, J. Descoeur, F. Coudore, E. Bourinet, and A. Eschalier Animal models of chemotherapy-evoked painful peripheral neuropathies Neurotherapeutics 6 2009 620 629
5. D.E. Baker Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum Rev Gastroenterol Disord 3 2003 31 38
6. E.E. Baulieu, P. Robel, and M. Schumacher Contemporary endocrinology 1999 Humana Press Totowa
7. D. Belelli, and J.J. Lambert Neurosteroids: endogenous regulators of the GABA(A) receptor Nat Rev Neurosci 6 2005 565 575
8. D. Bitran, R.J. Hilvers, and C.K. Kellogg Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor Brain Res 561 1991 157 161
9. M. Borgna, R. Lombardi, G. Lauria, P. Grezzi, C. Savino, R. Bianchi, N. Oggioni, A. Canta, F. Lanzani, S. Galbiati, B. Frigeni, G. Giussani, G. Tredici, and G. Cavaletti Intraepidermal innervation and tail nerve conduction velocity in neurotoxicity models: results of a correlation study in normal and pathological conditions J Peripher Nerv Syst 9 2004 104 105
10. R.D. Brinton, and J.M. Wang Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent Curr Alzheimer Res 3 2006 185 190
11. M.D. Brot, Y. Akwa, R.H. Purdy, G.F. Koob, and K.T. Britton The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors Eur J Pharmacol 325 1997 1 7
12. W. Cai, Y. Zhu, K. Furuya, Z. Li, M. Sokabe, and L. Chen Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage Neuropharmacology 55 2008 127 138
13. G. Cavaletti, G. Tredici, M.G. Petruccioli, E. Donde, P. Tredici, P. Marmiroli, C. Minoia, A. Ronchi, M. Bayssas, and G.G. Etienne Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat Eur J Cancer 37 2001 2457 2463
14. I. Ciriza, I. Azcoitia, and L.M. Garcia-Segura Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo J Neuroendocrinol 16 2004 58 63
15. I. Ciriza, P. Carrero, C.A. Frye, and L.M. Garcia-Segura Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective J Neurobiol 66 2006 916 928
16. C.R. Culy, D. Clemett, and L.R. Wiseman Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies Drugs 60 2000 895 924
17. B. Desoize, and C. Madoulet Particular aspects of platinum compounds used at present in cancer treatment Crit Rev Oncol Hematol 42 2002 317 325
18. P.M. Dougherty, J.P. Cata, A.W. Burton, K. Vu, and H.R. Weng Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain J Pain Symptom Manage 33 2007 166 179
19. J.P. Durand, J. Alexandre, L. Guillevin, and F. Goldwasser Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy Anticancer Drugs 16 2005 587 591
20. J.M. Extra, M. Marty, S. Brienza, and J.L. Misset Pharmacokinetics and safety profile of oxaliplatin Semin Oncol 25 1998 13 22
21. M. Gambhir, P.K. Mediratta, and K.K. Sharma Evaluation of the analgesic effect of neurosteroids and their possible mechanism of action Indian J Physiol Pharmacol 46 2002 202 208
22. E. Gamelin, L. Gamelin, L. Bossi, and S. Quasthoff Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures Semin Oncol 29 2002 21 33
23. L. Gamelin, M. Boisdron-Celle, R. Delva, V. Guerin-Meyer, N. Ifrah, A. Morel, and E. Gamelin Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer Clin Cancer Res 10 2004 4055 4061
24. P. Gauchan, T. Andoh, K. Ikeda, M. Fujita, A. Sasaki, A. Kato, and Y. Kuraishi Mechanical allodynia induced by paclitaxel, oxaliplatin and vincristine: different effectiveness of gabapentin and different expression of voltage-dependent calcium channel alpha(2)delta-1 subunit Biol Pharm Bull 32 2009 732 734
25. P. Gauchan, T. Andoh, A. Kato, and Y. Kuraishi Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice Neurosci Lett 458 2009 93 95
26. C.S. Goodchild, Z. Guo, and R. Nadeson Antinociceptive properties of neurosteroids I. Spinally-mediated antinociceptive effects of water-soluble aminosteroids Pain 88 2000 23 29
27. C.S. Goodchild, A. Robinson, and R. Nadeson Antinociceptive properties of neurosteroids IV: pilot study demonstrating the analgesic effects of alphadolone administered orally to humans Br J Anaesth 86 2001 528 534
28. P. Grant, and H.C. Pant Neurofilament protein synthesis and phosphorylation J Neurocytol 29 2000 843 872
29. L.D. Griffin, W. Gong, L. Verot, and S.H. Mellon Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone Nat Med 10 2004 704 711
30. A. Grothey Oxaliplatin-safety profile: neurotoxicity Semin Oncol 30 2003 5 13
31. K. Hargreaves, R. Dubner, F. Brown, C. Flores, and J. Joris A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia Pain 32 1988 77 88
32. J. Holmes, J. Stanko, M. Varchenko, H. Ding, V.J. Madden, C.R. Bagnell, S.D. Wyrick, and S.G. Chaney Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model Toxicol Sci 46 1998 342 351
33. A.M. Hosie, M.E. Wilkins, H.M. da Silva, and T.G. Smart Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites Nature 444 2006 486 489
34. S.M. Jamieson, J. Subramaniam, J.J. Liu, N.N. Jong, V. Ip, B. Connor, and M.J. McKeage Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue Mol Pain 5 2009 66
35. V. Jevtovic-Todorovic, D.F. Covey, and S.M. Todorovic Are neuroactive steroids promising therapeutic agents in the management of acute and chronic pain? Psychoneuroendocrinology 34 2009 S178 185
36. P. Jiang, C.X. Yang, Y.T. Wang, and T.L. Xu Mechanisms of modulation of pregnanolone on glycinergic response in cultured spinal dorsal horn neurons of rat Neuroscience 141 2006 2041 2050
37. E.K. Joseph, X. Chen, O. Bogen, and J.D. Levine Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy J Pain 9 2008 463 472
38. J. Kriz, Q. Zhu, J.P. Julien, and A.L. Padjen Electrophysiological properties of axons in mice lacking neurofilament subunit genes: disparity between conduction velocity and axon diameter in absence of NF-H Brain Res 885 2000 32 44
39. F. Labombarda, A. Pianos, P. Liere, B. Eychenne, S. Gonzalez, A. Cambourg, A.F. De Nicola, M. Schumacher, and R. Guennoun Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry Endocrinology 147 2006 1847 1859
40. E. Lang, A.H. Hord, and D. Denson Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy Pain 68 1996 151 155
41. C. Lappe-Siefke, S. Goebbels, M. Gravel, E. Nicksch, J. Lee, P.E. Braun, I.R. Griffiths, and K.A. Nave Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination Nat Genet 33 2003 366 374
42. G. Lauria, R. Lombardi, M. Borgna, P. Penza, R. Bianchi, C. Savino, A. Canta, G. Nicolini, P. Marmiroli, and G. Cavaletti Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation J Peripher Nerv Syst 10 2005 202 208
43. A.C. LeBlanc, J. Pringle, J. Lemieux, J.F. Poduslo, and C. Mezei Regulation of 2′,3′-cyclic nucleotide phosphodiesterase gene expression in experimental peripheral neuropathies Brain Res Mol Brain Res 15 1992 40 46
44. M.K. Lee, and D.W. Cleveland Neuronal intermediate filaments Annu Rev Neurosci 19 1996 187 217
45. B. Ling, N. Authier, D. Balayssac, A. Eschalier, and F. Coudore Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat Pain 128 2007 225 234
46. B. Ling, M.A. Coudore-Civiale, D. Balayssac, A. Eschalier, F. Coudore, and N. Authier Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat Toxicology 234 2007 176 184
47. G. Maksay, B. Laube, and H. Betz Subunit-specific modulation of glycine receptors by neurosteroids Neuropharmacology 41 2001 369 376
48. F. Marchand, A. Alloui, E. Chapuy, D. Jourdan, T. Pelissier, D. Ardid, A. Hernandez, and A. Eschalier Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats Pain 103 2003 229 235
49. G. Mathe, Y. Kidani, M. Noji, R. Maral, C. Bourut, and E. Chenu Antitumor activity of l-OHP in mice Cancer Lett 27 1985 135 143
50. M.J. McKeage, F.E. Boxall, M. Jones, and K.R. Harrap Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the rat Cancer Res 54 1994 629 631
51. R.C. Melcangi, L.M. Garcia-Segura, and A.G. Mensah-Nyagan Neuroactive steroids: state of the art and new perspectives Cell Mol Life Sci 65 2008 777 797
52. A.G. Mensah-Nyagan, J.L. Do-Rego, D. Beaujean, V. Luu-The, G. Pelletier, and H. Vaudry Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system Pharmacol Rev 51 1999 63 81
53. L. Meyer, C. Venard, V. Schaeffer, C. Patte-Mensah, and A.G. Mensah-Nyagan The biological activity of 3 alpha-hydroxysteroid oxido-reductase in the spinal cord regulates thermal and mechanical pain thresholds after sciatic nerve injury Neurobiol Dis 30 2008 30 41
54. L. Meyer, C. Patte-Mensah, O. Taleb, and A.G. Mensah-Nyagan Cellular and functional evidence for a protective action of neurosteroids against vincristine chemotherapy-induced painful neuropathy Cell Mol Life Sci 67 2010 3017 3034
55. F.M. Muggia Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers Semin Oncol 31 2004 17 24
56. R. Nadeson, and C.S. Goodchild Antinociceptive properties of neurosteroids II. Experiments with Saffan and its components alphaxalone and alphadolone to reveal separation of anaesthetic and antinociceptive effects and the involvement of spinal cord GABA(A) receptors Pain 88 2000 31 39
57. A.K. Naik, S. Pathirathna, and V. Jevtovic-Todorovic GABAA receptor modulation in dorsal root ganglia in vivo affects chronic pain after nerve injury Neuroscience 154 2008 1539 1553
58. S. Pathirathna, B.C. Brimelow, M.M. Jagodic, K. Krishnan, X. Jiang, C.F. Zorumski, S. Mennerick, D.F. Covey, S.M. Todorovic, and V. Jevtovic-Todorovic New evidence that both T-type calcium channels and GABAA channels are responsible for the potent peripheral analgesic effects of 5 alpha-reduced neuroactive steroids Pain 114 2005 429 443
59. C. Patte-Mensah, T.M. Penning, and A.G. Mensah-Nyagan Anatomical and cellular localization of neuroactive 5 alpha/3 alpha-reduced steroid-synthesizing enzymes in the spinal cord J Comp Neurol 477 2004 286 299
60. C. Patte-Mensah, C. Kibaly, and A.G. Mensah-Nyagan Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception Proc Natl Acad Sci USA 102 2005 9044 9049
61. C. Patte-Mensah, C. Kibaly, D. Boudard, V. Schaeffer, A. Béglé, S. Saredi, L. Meyer, and A.G. Mensah-Nyagan Neurogenic pain and steroid synthesis in the spinal cord J Mol Neurosci 28 2006 17 32
62. T. Petit, A. Benider, A. Yovine, P. Bougnoux, D. Spaeth, F. Maindrault-Goebel, D. Serin, J.D. Tigaud, J.C. Eymard, H. Simon, B. Bertaux, S. Brienza, and E. Cvitkovic Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer Anticancer Drugs 17 2006 337 343
63. S.K. Ravula, M.S. Wang, M.A. McClain, S.A. Asress, B. Frazier, and J.D. Glass Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degeneration Neurosci Lett 415 2007 34 39
64. R. Rupprecht, G. Rammes, D. Eser, T.C. Baghai, C. Schule, C. Nothdurfter, T. Troxler, C. Gentsch, H.O. Kalkman, F. Chaperon, V. Uzunov, K.H. McAllister, V. Bertaina-Anglade, C.D. La Rochelle, D. Tuerck, A. Floesser, B. Kiese, M. Schumacher, R. Landgraf, F. Holsboer, and K. Kucher Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects Science 325 2009 490 493
65. I. Sayeed, Q. Guo, S.W. Hoffman, and D.G. Stein Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion Ann Emerg Med 47 2006 381 389
66. M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.E. Baulieu Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system Endocr Rev 28 2007 387 439
67. D. Screnci, M.J. McKeage, P. Galettis, T.W. Hambley, B.D. Palmer, and B.C. Baguley Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs Br J Cancer 82 2000 966 972
68. G. Shaw, M. Osborn, and K. Weber Reactivity of a panel of neurofilament antibodies on phosphorylated and dephosphorylated neurofilaments Eur J Cell Biol 42 1986 1 9
69. C. Siau, W. Xiao, and G.J. Bennett Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells Exp Neurol 201 2006 507 514
70. T.J. Sprinkle 2′,3′-Cyclic nucleotide 3′- phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system Crit Rev Neurobiol 4 1989 235 301
71. L.E. Ta, P.A. Low, and A.J. Windebank Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli Mol Pain 5 2009 9
72. K.D. Tanner, D.B. Reichling, and J.D. Levine Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat J Neurosci 18 1998 6480 6491
73. T. Tashiro, Y. Kawada, Y. Sakurai, and Y. Kidani Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data Biomed Pharmacother 43 1989 251 260
74. E. Timby, M. Balgard, S. Nyberg, O. Spigset, A. Andersson, J. Porankiewicz-Asplund, R.H. Purdy, D. Zhu, T. Backstrom, and I.S. Poromaa Pharmacokinetic and behavioral effects of allopregnanolone in healthy women Psychopharmacology (Berl) 186 2006 414 424
75. V. Uzunova, Y. Sheline, J.M. Davis, A. Rasmusson, D.P. Uzunov, E. Costa, and A. Guidotti Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine Proc Natl Acad Sci USA 95 1998 3239 3244
76. J.M. Wang, P.B. Johnston, B.G. Ball, and R.D. Brinton The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression J Neurosci 25 2005 4706 4718
77. J.M. Wang, C. Singh, L. Liu, R.W. Irwin, S. Chen, E.J. Chung, R.F. Thompson, and R.D. Brinton Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease Proc Natl Acad Sci USA 107 2010 6498 6503
78. R.H. Wilson, T. Lehky, R.R. Thomas, M.G. Quinn, M.K. Floeter, and J.L. Grem Acute oxaliplatin-induced peripheral nerve hyperexcitability J Clin Oncol 20 2002 1767 1774
79. J.E. Yoshino, M.P. Dinneen, T.J. Sprinkle, and G.H. DeVries Localization of 2′,3′-cyclic nucleotide 3′-phosphodiesterase on cultured Schwann cells Brain Res 325 1985 199 203
80. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 1983 109 110